Neural stimulation has a variety of applications in neuroscience research and clinical therapies. Conventionally, stimulation is delivered by implanted electrodes, such as in intracortical microstimulation (ICMS) and deep brain stimulation (DBS). However, long-term reliability associated with the electrode-tissue interface remains a fundamental challenge [1], due to foreign body responses that can lead to glial scar formation and encapsulation of electrodes (Fig. 17.5.1). Magnetic stimulation has emerged as a promising alternative to overcome this challenge, as no direct contact is needed between the stimulation coil and tissues. Its efficacy has been clinically verified through FDA-approved transcranial magnetic stimulation (TMS) for treating neurological disorders. However, TMS devices are power-hungry and bulky (Fig. 17.5.1), which not only restricts patient accessibility but also limits the spatial resolution of the stimulation.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: